These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31694268)

  • 21. Kinetic, Thermodynamic, and Crystallographic Studies of 2-Triazolylthioacetamides as Verona Integron-Encoded Metallo-β-Lactamase 2 (VIM-2) Inhibitor.
    Xiang Y; Zhang YJ; Ge Y; Zhou Y; Chen C; Wahlgren WY; Tan X; Chen X; Yang KW
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31906402
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amino Acid Thioester Derivatives: A Highly Promising Scaffold for the Development of Metallo-β-lactamase L1 Inhibitors.
    Liu XL; Shi Y; Kang JS; Oelschlaeger P; Yang KW
    ACS Med Chem Lett; 2015 Jun; 6(6):660-4. PubMed ID: 26101570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diaryl-substituted azolylthioacetamides: Inhibitor discovery of New Delhi metallo-β-lactamase-1 (NDM-1).
    Zhang YL; Yang KW; Zhou YJ; LaCuran AE; Oelschlaeger P; Crowder MW
    ChemMedChem; 2014 Nov; 9(11):2445-8. PubMed ID: 25048031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
    Muteeb G; Alsultan A; Farhan M; Aatif M
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-heterocyclic dicarboxylic acids: broad-spectrum inhibitors of metallo-β-lactamases with co-antibacterial effect against antibiotic-resistant bacteria.
    Feng L; Yang KW; Zhou LS; Xiao JM; Yang X; Zhai L; Zhang YL; Crowder MW
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5185-9. PubMed ID: 22796180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Alkyl-1,2,4-triazole-3-thione analogues as metallo-β-lactamase inhibitors.
    Gavara L; Legru A; Verdirosa F; Sevaille L; Nauton L; Corsica G; Mercuri PS; Sannio F; Feller G; Coulon R; De Luca F; Cerboni G; Tanfoni S; Chelini G; Galleni M; Docquier JD; Hernandez JF
    Bioorg Chem; 2021 Aug; 113():105024. PubMed ID: 34116340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triazolylthioacetamide: A Valid Scaffold for the Development of New Delhi Metallo-β-Lactmase-1 (NDM-1) Inhibitors.
    Zhai L; Zhang YL; Kang JS; Oelschlaeger P; Xiao L; Nie SS; Yang KW
    ACS Med Chem Lett; 2016 Apr; 7(4):413-7. PubMed ID: 27096051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of environment-sensitive fluorescent probes for detecting and inhibiting metallo-β-lactamase.
    Chen C; Xiang Y; Yang KW
    Bioorg Chem; 2022 Nov; 128():106048. PubMed ID: 35952448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorinated captopril analogues inhibit metallo-β-lactamases and facilitate structure determination of NDM-1 binding pose.
    Kondratieva A; Palica K; Frøhlich C; Hovd RR; Leiros HS; Erdelyi M; Bayer A
    Eur J Med Chem; 2024 Feb; 266():116140. PubMed ID: 38242072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diaryl-substituted thiosemicarbazone: A potent scaffold for the development of New Delhi metallo-β-lactamase-1 inhibitors.
    Li JQ; Sun LY; Jiang Z; Chen C; Gao H; Chigan JZ; Ding HH; Yang KW
    Bioorg Chem; 2021 Feb; 107():104576. PubMed ID: 33383326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dithiocarbamates combined with copper for revitalizing meropenem efficacy against NDM-1-producing Carbapenem-resistant Enterobacteriaceae.
    Chen C; Yang KW; Zhai L; Ding HH; Chigan JZ
    Bioorg Chem; 2022 Jan; 118():105474. PubMed ID: 34794102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel partially reversible NDM-1 inhibitors based on the naturally occurring houttuynin.
    Wang L; Liang Y; Luo P; Huang M; Wan Y
    Bioorg Chem; 2024 Jun; 147():107328. PubMed ID: 38583248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dipicolinic Acid Derivatives as Inhibitors of New Delhi Metallo-β-lactamase-1.
    Chen AY; Thomas PW; Stewart AC; Bergstrom A; Cheng Z; Miller C; Bethel CR; Marshall SH; Credille CV; Riley CL; Page RC; Bonomo RA; Crowder MW; Tierney DL; Fast W; Cohen SM
    J Med Chem; 2017 Sep; 60(17):7267-7283. PubMed ID: 28809565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3-Bromopyruvate as a potent covalently reversible inhibitor of New Delhi metallo-β-lactamase-1 (NDM-1).
    Kang PW; Su JP; Sun LY; Gao H; Yang KW
    Eur J Pharm Sci; 2020 Jan; 142():105161. PubMed ID: 31751778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting clinically-relevant metallo-β-lactamases: from high-throughput docking to broad-spectrum inhibitors.
    Brindisi M; Brogi S; Giovani S; Gemma S; Lamponi S; De Luca F; Novellino E; Campiani G; Docquier JD; Butini S
    J Enzyme Inhib Med Chem; 2016; 31(sup1):98-109. PubMed ID: 27121013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermokinetic profile of NDM-1 and its inhibition by small carboxylic acids.
    Wang Q; He Y; Lu R; Wang WM; Yang KW; Fan HM; Jin Y; Blackburn GM
    Biosci Rep; 2018 Apr; 38(2):. PubMed ID: 29507059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-time activity assays of β-lactamases in living bacterial cells: application to the inhibition of antibiotic-resistant E. coli strains.
    Ge Y; Zhou YJ; Yang KW; Zhang YL; Xiang Y; Zhang YJ
    Mol Biosyst; 2017 Oct; 13(11):2323-2327. PubMed ID: 28906528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Azolylthioacetamide: A Highly Promising Scaffold for the Development of Metallo-β-lactamase Inhibitors.
    Yang SK; Kang JS; Oelschlaeger P; Yang KW
    ACS Med Chem Lett; 2015 Apr; 6(4):455-60. PubMed ID: 25893049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem.
    Tehrani KHME; Brüchle NC; Wade N; Mashayekhi V; Pesce D; van Haren MJ; Martin NI
    ACS Infect Dis; 2020 Jun; 6(6):1366-1371. PubMed ID: 32227874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory Potential of Polyclonal Camel Antibodies against New Delhi Metallo-β-lactamase-1 (NDM-1).
    Ben Abderrazek R; Chammam S; Ksouri A; Perilli M; Dhaouadi S; Mdini I; Benlasfar Z; Amicosante G; Bouhaouala-Zahar B; Piccirilli A
    Molecules; 2020 Sep; 25(19):. PubMed ID: 32998307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.